Download Citation
Article Source:
Combination of Bortezomib and Mitotic Inhibitors Down-Modulate Bcr-Abl and Efficiently Eliminates Tyrosine-Kinase Inhibitor Sensitive and Resistant Bcr-Abl-Positive Leukemic Cells
Bucur O,
Stancu AL,
Goganau I,
Petrescu SM,
Pennarun B,
et al.
(2013)
Combination of Bortezomib and Mitotic Inhibitors Down-Modulate Bcr-Abl and Efficiently Eliminates Tyrosine-Kinase Inhibitor Sensitive and Resistant Bcr-Abl-Positive Leukemic Cells.
PLOS ONE 8(10): e77390.
https://doi.org/10.1371/journal.pone.0077390